GO
Loading...

India

More

  • LONDON, Oct 2- Barclays has promoted two of its top consumer banking bosses to its executive committee as the British bank's new boss puts more focus on traditional banking after criticism of its rapid growth in higher risk investment banking.

  • Iranian leader: `Psychological' blows hit currency Tuesday, 2 Oct 2012 | 9:47 AM ET

    TEHRAN, Iran-- President Mahmoud Ahmadinejad blamed the steep drop in Iran's currency Tuesday to "psychological pressures" linked to Western sanctions over Tehran's nuclear program. The U.S. and its allies have imposed the punishing measures to try to persuade Iran to negotiate over its nuclear program, which the West says is aimed at developing atomic weapons.

  • Acuity Brands results miss Street Tuesday, 2 Oct 2012 | 9:40 AM ET

    Oct 2- Lighting fixture maker Acuity Brands Inc's. Net income fell to $33.3 million, or 78 cents per share, from $34.2 million, or 79 cents per share, a year earlier. Shares of the Atlanta, Georgia- based company touched a low of $58.57 in early trading on the New York Stock Exchange.

  • US stock futures gain on latest positive data Tuesday, 2 Oct 2012 | 9:26 AM ET

    CoreLogic, a private real estate data provider, also said prices rose 0.3 percent in August from July, the sixth straight month of price gains. The CoreLogic report comes a day after the manufacturing survey from the Institute for Supply Management also pointed to an improvement.

  • The Nasdaq Composite Index added 14.98 points, or 0.48 percent, to 3,128.51. **ARQULE INC $2.14, down 57.73 pct The biotechnology company and Japan's Daiichi Sankyo Co Ltd. **SIRIUS XM RADIO INC, $2.62, up 2 pct.

  • Oct 2- Cell Therapeutics Inc said U.S. health regulators granted orphan drug status to its brain cancer drug, sending the company's shares up 26 percent in premarket trading. It is estimated that there will be 10,000-12,000 new cases of GBM diagnosed in the United States this year alone, the company said, citing data from the National Cancer Institute.

  • John Wiley to buy Deltak.edu for $220 mln Tuesday, 2 Oct 2012 | 8:42 AM ET

    Oct 2- Publisher John Wiley& Sons Inc said it will buy privately held Deltak.edu LLC, a higher education and online learning services company, for $220 million to bolster its digital learning offerings. The deal is expected to close by October-end. After the acquisition, Deltak's more than 300 employees would become part of Wiley.

  • Proxy advisory firm ISS receives SEC Wells notice Tuesday, 2 Oct 2012 | 8:38 AM ET

    Oct 2- Investment analysis and market index company MSCI Inc said its proxy advisory unit, Institutional Shareholder Services, received a Wells Notice on Sept. 14 related to a whistleblower complaint made against an employee of the unit.

  • S&P 500 futures rose 7.7 points, Dow Jones industrial average futures rose 23 points, and Nasdaq 100 futures. The biotechnology company and Japan's Daiichi Sankyo Co Ltd. CNBC Mad Money host Jim Cramer said the Internet company has "real value because it has some really terrific assets", and new Chief Executive Marissa Mayer is committed to unlocking its value.

  • Oct 2- Oil and natural gas company Diamondback Energy Inc said it expected to sell 12.5 million shares for between $17 and $19 per share in its initial public offering. Diamondback, backed by Gulfport Energy Corp and DB Energy Holdings LLC, in February filed for an IPO of up to $50 million.

  • MOSCOW, Oct 2- Russia's economy should sustain its current 4 percent growth rate over the next three years, President Vladimir Putin said on Tuesday, playing up its relatively strong performance as the global economy slows.

  • MARKET PULSE-Boeing, Yahoo, Oracle Tuesday, 2 Oct 2012 | 7:41 AM ET

    U.S. stock index futures pointed to a higher open on Wall Street on Tuesday, with futures for the S&P 500, the Dow Jones and the Nasdaq 100 up between 0.2 and 0.3 percent. CNBC Mad Money host Jim Cramer said the Internet company has "real value because it has some really terrific assets", and new Chief Executive Marissa Mayer is committed to unlocking its value.

  • MARKET PULSE- Tuesday, 2 Oct 2012 | 7:33 AM ET

    U.S. stock index futures pointed to a higher open on Wall Street on Tuesday, with futures for the S&P 500, the Dow Jones and the Nasdaq 100 up between 0.2 and 0.3 percent. CNBC Mad Money host Jim Cramer said the Internet company has "real value because it has some really terrific assets", and new Chief Executive Marissa Mayer is committed to unlocking its value.

  • NEW DELHI, Oct 2- India's Kingfisher Airlines Ltd, controlled by liquor baron Vijay Mallya, cancelled all flights through Thursday because of labour unrest and was ordered by the aviation regulator to submit a revival plan before it can fly again.

  • Asia Fuel Oil-Oct/Nov slips further on weak demand Tuesday, 2 Oct 2012 | 7:19 AM ET

    SINGAPORE, Oct 2- Asia's fuel oil market continued to weaken on Tuesday, with the prompt inter-month spread easing to a six-week low on lacklustre demand at a time when more supply is emerging. The balance October/November inter-month spread eased 50 cents to a backwardation of $2.38 a tonne, lowest since Aug. 21, according to Reuters data.

  • Morocco delays target date to cap sugar imports Tuesday, 2 Oct 2012 | 7:15 AM ET

    *Morocco delays target to 2020. RABAT, Oct 2- Morocco is to delay a plan to cap sugar import needs at 45 percent its annual demand by end-2013 after bad weather hit farming this year and as an investment vehicle controlled by the ruling monarchy seeks to divest the sugar industry's monopoly.

  • Asia Naphtha/Gasoline-Naphtha margins snap gains Tuesday, 2 Oct 2012 | 7:15 AM ET

    SINGAPORE, Oct 2- The Asian naphtha price extended losses on Tuesday to reach a three-session low of $966 while margins snapped four sessions of gains and fell to $124.95 a tonne as squeezed petrochemical margins overshadowed the firm gasoline prices in the West.

  • DOJ drops inquiry against DaVita without charges Tuesday, 2 Oct 2012 | 7:00 AM ET

    The investigation initiated by the U.S. Attorney's Office for St. Louis in 2005 covered the company's joint ventures, financial relationships with physicians and services provided to patients, and included the administration and billing of DaVita's anemia drug, Epogen.

  • Another top executive at the JPMorgan unit that lost $5.8 billion on derivatives trades this year is leaving the company. The real estate investment manager named Jeroen Verheijden as a senior vice-president to spearhead the company's client business in the UK, the euro zone and the Middle East.

  • Lilly, Boehringer's diabetes drug shows promise Tuesday, 2 Oct 2012 | 6:49 AM ET

    Oct 2- Eli Lilly and Co and German drugmaker Boehringer Ingelheim Pharmaceuticals Inc said data from two trials of their experimental diabetes treatment showed the drug reduced blood pressure in patients. Diabetes patients are prone to high blood pressure, which can raise the risk of other health complications.